VenoStent

Pre-clinical

Houston, United StatesFounded 2017venostent.com

Dialysis is the primary lifeline for patients with end-stage renal disease, but dialysis access sites are prone to failure, reducing the quality and length of life for patients.

Founded

2017

Focus

Medical DevicesCardiovascular

About

Dialysis is the primary lifeline for patients with end-stage renal disease, but dialysis access sites are prone to failure, reducing the quality and length of life for patients.

Funding History

2

Total raised: $17M

Series A$12MUndisclosedAug 15, 2023

Seed$5MUndisclosedMay 15, 2021

Company Info

TypePrivate

Founded2017

LocationHouston, United States

StagePre-clinical

Contact

Sectors

Drug Delivery & Formulation

SIMILAR COMPANIES

BASi Research Products

Pre-clinical · West Lafayette

Bay BioSciences

Pre-clinical · San Francisco

Pre-clinical · Cambridge

Pre-clinical · Memphis

Belcher Pharmaceuticals

Pre-clinical · Miami

Is this your company?

Claim your profile to update information, add pipeline data, and connect with investors.